Susquehanna International Group’s Acer Therapeutics Inc Warrant ACERW Stock Holding History

Susquehanna International Group’s Portfolio ACERW Stock Details ACERW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-1,001,125	Closed	-$3K	–	10997
2018 Q1	$3K	Buy	+1,001,125	New	+$7.91K	﹤0.01%	9206

Susquehanna International Group's ACERW Position: Q2 2018 in Review

Susquehanna International Group sold out of Acer Therapeutics Inc Warrant (ACERW) in Q2 2018, closing a stake of 1,001,125 shares — an estimated $3K sold.

Susquehanna International Group first reported a position in ACERW in Q1 2018 and held it in 1 quarter. The position peaked at $3K in Q1 2018. 0 funds tracked by Wall St. Rank hold ACERW as of Q2 2018.

Susquehanna International Group reported no remaining Acer Therapeutics Inc Warrant position as of Q2 2018 after selling out during the quarter.
Susquehanna International Group sold 1,001,125 Acer Therapeutics Inc Warrant shares in Q2 2018, an estimated $3K.
Susquehanna International Group first reported a position in Acer Therapeutics Inc Warrant in Q1 2018 and held it in 1 quarter.
Susquehanna International Group's Acer Therapeutics Inc Warrant position peaked at $3K in Q1 2018.
0 funds tracked by Wall St. Rank held Acer Therapeutics Inc Warrant as of Q2 2018.

Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.